Scorpion Therapeutics

Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.

Headquarters Boston, MA
Pipeline Preclinical
Twitter @_ScorpionTx​
LinkedIn Scorpion Therapeutics​